« Return to News | CROs/Service Providers

GVK Biosciences selects GGA as new distributor in Taiwan

Monday, February 25, 2013 11:55 AM

GVK Biosciences, a provider of databases and services to the life sciences industry, has selected Genesis Genetics Asia (GGA) as its distributor for its Informatics Database products and services in Taiwan.

"Genesis Genetics Asia is recognized as the premier distributor in the life sciences industry in Taiwan and we are pleased to work with a high caliber sales team that will help expand our customer base in the region," said Sreeni Devidas, vice president, business development, informatics, GVK Biosciences. "GGA will be responsible for distribution of the SAR, Biomarker and Clinical Outcomes databases and would also promote the BioIT and Data Curation services offered by GVK BIO."

Dr. Pei-Li Li, vice president, Molecular Science Center, Genesis Genetics Asia, said, "GVK BIO's comprehensive products and superior BioIT services are powerful additions to GGA's portfolio in informatics business. We are pleased to become GVK BIO's distribution partner as it will enable our company to provide researchers in the Taiwanese pharma-biotech industries with such great tools. The ability to search for the desired biomarkers; make queries and compare drug structures and activities; analyze, design and predict the successful outcome in clinical trials will give impetus to Taiwan's pharmaceutical industry in progressing ahead."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.